Literature DB >> 31740571

Management of Membranous Nephropathy after MENTOR.

Claire Trivin-Avillach1, Laurence H Beck2.   

Abstract

Entities:  

Keywords:  B-lymphocytes; MENTOR; adrenal cortex hormones; alkylating agents; autoantibodies; calcineurin inhibitors; cyclosporine; epitopes; follow-up studies; human PLA2R1 protein; humans; immunosuppressive agents; membranous glomerulonephritis; nephrotic syndrome; phospholipase A2 receptors; proteinuria; renal insufficiency; rituximab; serum albumin

Mesh：

Substances：

Year:  2019        PMID： 31740571      PMCID： PMC7057305          DOI： 10.2215/CJN.10240819

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

1.  Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.

Authors:  Fernando C Fervenza; Gerald B Appel; Sean J Barbour; Brad H Rovin; Richard A Lafayette; Nabeel Aslam; Jonathan A Jefferson; Patrick E Gipson; Dana V Rizk; John R Sedor; James F Simon; Ellen T McCarthy; Paul Brenchley; Sanjeev Sethi; Carmen Avila-Casado; Heather Beanlands; John C Lieske; David Philibert; Tingting Li; Lesley F Thomas; Dolly F Green; Luis A Juncos; Lada Beara-Lasic; Samuel S Blumenthal; Amy N Sussman; Stephen B Erickson; Michelle Hladunewich; Pietro A Canetta; Lee A Hebert; Nelson Leung; Jay Radhakrishnan; Heather N Reich; Samir V Parikh; Debbie S Gipson; Dominic K Lee; Bruno R da Costa; Peter Jüni; Daniel C Cattran
Journal:  N Engl J Med       Date:  2019-07-04       Impact factor: 91.245

2.  Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody.

Authors:  K Dahan; C Johannet; E Esteve; E Plaisier; H Debiec; P Ronco
Journal:  Kidney Int       Date:  2019-01       Impact factor: 10.612

3.  Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab.

Authors:  Anne-Els van de Logt; Karine Dahan; Alexandra Rousseau; Renate van der Molen; Hanna Debiec; Pierre Ronco; Jack Wetzels
Journal:  Kidney Int       Date:  2018-04       Impact factor: 10.612

4.  Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.

Authors:  Jan A J G van den Brand; Piero Ruggenenti; Antonietta Chianca; Julia M Hofstra; Annalisa Perna; Barbara Ruggiero; Jack F M Wetzels; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2017-05-09       Impact factor: 10.121

5.  High-Dose Rituximab and Early Remission in PLA2R1-Related Membranous Nephropathy.

Authors:  Barbara Seitz-Polski; Karine Dahan; Hanna Debiec; Alexandra Rousseau; Marine Andreani; Christelle Zaghrini; Michel Ticchioni; Alessandra Rosenthal; Sylvia Benzaken; Ghislaine Bernard; Gérard Lambeau; Pierre Ronco; Vincent L M Esnault
Journal:  Clin J Am Soc Nephrol       Date:  2019-07-24       Impact factor: 8.237

6.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

Authors:  Laurence H Beck; Fernando C Fervenza; David M Beck; Ramon G B Bonegio; Fahim A Malik; Stephen B Erickson; Fernando G Cosio; Daniel C Cattran; David J Salant
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

7.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.

Authors:  Laurence H Beck; Ramon G B Bonegio; Gérard Lambeau; David M Beck; David W Powell; Timothy D Cummins; Jon B Klein; David J Salant
Journal:  N Engl J Med       Date:  2009-07-02       Impact factor: 91.245

8.  Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy.

Authors:  Piero Ruggenenti; Hanna Debiec; Barbara Ruggiero; Antonietta Chianca; Timothee Pellé; Flavio Gaspari; Flavio Suardi; Elena Gagliardini; Silvia Orisio; Ariela Benigni; Pierre Ronco; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2015-03-24       Impact factor: 10.121

9.  Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up.

Authors:  Karine Dahan; Hanna Debiec; Emmanuelle Plaisier; Marine Cachanado; Alexandra Rousseau; Laura Wakselman; Pierre-Antoine Michel; Fabrice Mihout; Bertrand Dussol; Marie Matignon; Christiane Mousson; Tabassome Simon; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2016-06-27       Impact factor: 10.121

10.  Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy.

Authors:  Barbara Seitz-Polski; Hanna Debiec; Alexandra Rousseau; Karine Dahan; Christelle Zaghrini; Christine Payré; Vincent L M Esnault; Gérard Lambeau; Pierre Ronco
Journal:  J Am Soc Nephrol       Date:  2017-11-07       Impact factor: 10.121
  10 in total
  5 in total

1.  Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy.

Authors:  Leonella Luzardo; Gabriela Ottati; Jimena Cabrera; Hernando Trujillo; Mariela Garau; Carlota González Bedat; Ruben Coitiño; María H Aunchayna; José Santiago; Graciela Baldovinos; Ricardo Silvariño; Alejandro Ferreiro; Francisco González-Martínez; Liliana Gadola; Oscar Noboa; Hena Caorsi
Journal:  Kidney360       Date:  2020-08-07

Review 2.  How Does Herbal Medicine Treat Idiopathic Membranous Nephropathy?

Authors:  Zhendong Feng; Wenbin Liu; Han Xue Jiang; Haoran Dai; Chang Gao; Zhaocheng Dong; Yu Gao; Fei Liu; Zihan Zhang; Qihan Zhao; Lei Zhang; Baoli Liu
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

3.  Th17-Immune Response in Patients With Membranous Nephropathy Is Associated With Thrombosis and Relapses.

Authors:  Marion Cremoni; Vesna Brglez; Sandra Perez; Fabrice Decoupigny; Kévin Zorzi; Marine Andreani; Alexandre Gérard; Sonia Boyer-Suavet; Caroline Ruetsch; Sylvia Benzaken; Vincent Esnault; Barbara Seitz-Polski
Journal:  Front Immunol       Date:  2020-11-26       Impact factor: 7.561

4.  Long-Term Follow-Up of Cyclical Cyclophosphamide and Steroids Versus Tacrolimus and Steroids in Primary Membranous Nephropathy.

Authors:  Raja Ramachandran; Vinod Kumar; Joyita Bharati; Brad Rovin; Ritambhra Nada; Vivek Kumar; Manish Rathi; Vivekanand Jha; Krishan Lal Gupta; Harbir Singh Kohli
Journal:  Kidney Int Rep       Date:  2021-08-10

5.  Long-term B cell depletion associates with regeneration of kidney function.

Authors:  Susanne V Fleig; Franz F Konen; Christoph Schröder; Jessica Schmitz; Stefan Gingele; Jan H Bräsen; Svjetlana Lovric; Bernhard M W Schmidt; Hermann Haller; Thomas Skripuletz; Sibylle von Vietinghoff
Journal:  Immun Inflamm Dis       Date:  2021-07-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.